Deutsche Bank’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Deutsche Bank’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,633,461	Closed	-$30.5M	–	4455
2022 Q1	$30.5M	Buy	1,633,461 +1,301,160	+392%	+$23.4M	0.01%	725
2021 Q4	$7.11M	Buy	332,301 +113,912	+52%	+$2.24M	﹤0.01%	1264
2021 Q3	$4.04M	Buy	218,389 +59,428	+37%	+$1.2M	﹤0.01%	1633
2021 Q2	$3.4M	Buy	158,961 +26,042	+20%	+$530K	﹤0.01%	1784
2021 Q1	$2.56M	Buy	+132,919	New	+$2.34M	﹤0.01%	1985

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deutsche Bank's OCDX Position: Q2 2022 in Review

Deutsche Bank sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 1,633,461 shares — an estimated $30.5M sold.

Deutsche Bank first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $30.5M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Deutsche Bank reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 1,633,461 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $30.5M.
Deutsche Bank first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Deutsche Bank's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $30.5M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.